Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors
- 1 August 2020
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 200, 112448
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
This publication has 55 references indexed in Scilit:
- Critical role of anti-apoptotic Bcl-2 protein phosphorylation in mitotic deathCell Death & Disease, 2013
- Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3′,4′,5′-trimethoxybenzoyl)Thiazoles as Novel Anticancer AgentsJournal of Medicinal Chemistry, 2012
- Role of Cyclin B1/Cdc2 Up-Regulation in the Development of Mitotic Prometaphase Arrest in Human Breast Cancer Cells Treated with NocodazolePLOS ONE, 2011
- Synthesis and Antitumor Molecular Mechanism of Agents Based on Amino 2‐(3′,4′,5′‐Trimethoxybenzoyl)benzo[b]furan: Inhibition of Tubulin and Induction of ApoptosisChemMedChem, 2011
- Discovery of 7-Hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting PropertiesJournal of Medicinal Chemistry, 2011
- Synthesis of 2‐(1‐Phenylvinyl)benzofurans and 2‐(1‐Phenylvinyl)indoles as Antimitotic Agents by a Tandem Palladium‐Assisted Coupling‐Cyclization Reaction between 1‐Phenylvinyl Iodides and ortho‐Substituted ArylalkynesEuropean Journal of Organic Chemistry, 2011
- Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neckAnnals of Oncology, 2011
- Synthesis and biological evaluation of 2-(3′,4′,5′-trimethoxybenzoyl)-3-N,N-dimethylamino benzo[b]furan derivatives as inhibitors of tubulin polymerizationBioorganic & Medicinal Chemistry, 2008
- Spindle checkpoint function and cellular sensitivity to antimitotic drugsMolecular Cancer Therapeutics, 2006
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4Cellular and Molecular Life Sciences, 1989